Literature DB >> 7636384

Participation of pulmonary alveolar epithelial cells in lung inflammation.

R H Simon1, R Paine.   

Abstract

As our understanding of pulmonary inflammation improves, the complexity of the mechanisms involved becomes more and more apparent. The number of soluble inflammatory mediators that are being recognized and characterized is increasing rapidly. The major purpose of this review is to emphasize that developing a comprehensive understanding of pulmonary inflammation requires investigations that encompass all of the cellular components. More than just a stage on which inflammatory processes are played out, the alveolar epithelium can participate in virtually all aspects of inflammation, including initiation, amplification, down-regulation, and tissue repair. By directing the powerful tools of cellular and molecular biology to study the entire cast of cellular players, a more complete understanding of inflammation will surely result. Such a comprehensive approach should assist in the development of means to prevent and treat inflammatory lung diseases.

Entities:  

Mesh:

Year:  1995        PMID: 7636384

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  18 in total

1.  Playing "telephone": bioactive lipids as mediators of intercompartmental communication in the alveolus.

Authors:  M Peters-Golden
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin.

Authors:  T Betsuyaku; Y Fukuda; W C Parks; J M Shipley; R M Senior
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Formation of reactive oxygen species in rat epithelial cells upon stimulation with fly ash.

Authors:  K Voelkel; H F Krug; S Diabaté
Journal:  J Biosci       Date:  2003-02       Impact factor: 1.826

4.  Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice.

Authors:  Y Bergeron; N Ouellet; A M Deslauriers; M Simard; M Olivier; M G Bergeron
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

5.  Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli.

Authors:  P J Converse; A M Dannenberg; J E Estep; K Sugisaki; Y Abe; B H Schofield; M L Pitt
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

6.  RNA interference as a potential therapeutic treatment for inflammation associated lung injury.

Authors:  Joanne Lomas-Neira; Chun-Shiang Chung; Alfred Ayala
Journal:  Int J Clin Exp Med       Date:  2008-02-25

Review 7.  Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis.

Authors:  Eric S White; Michael H Lazar; Victor J Thannickal
Journal:  J Pathol       Date:  2003-11       Impact factor: 7.996

8.  Enhanced expression of 70-kilodalton heat shock protein limits cell division in a sepsis-induced model of acute respiratory distress syndrome.

Authors:  Zohar Bromberg; Nichelle Raj; Pierre Goloubinoff; Clifford S Deutschman; Yoram G Weiss
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

9.  Induction of nitric oxide release from the human alveolar epithelial cell line A549: an in vitro correlate of innate immune response to Mycobacterium tuberculosis.

Authors:  Sugata Roy; Sadhna Sharma; Monika Sharma; Ramesh Aggarwal; Mridula Bose
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

10.  Characterization of pentraxin 3 in the horse and its expression in airways.

Authors:  Eve Ramery; Laurence Fievez; Audrey Fraipont; Fabrice Bureau; Pierre Lekeux
Journal:  Vet Res       Date:  2009-10-29       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.